Autor: "Lamb CA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.
Autorzy:: Dart RJ; Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.; Department of Gastroenterology, Guy's and St Thomas' Foundation Trust, London, UK.
Zlatareva I; Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Vantourout P; Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Theodoridis E; Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Amar A; Department of Medical and Molecular Genetics, King's College London, London, UK.
Kannambath S; National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Genomics Centre, King's College London, London, UK.
East P; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
Recaldin T; GammaDelta Therapeutics Ltd., London, UK.
Mansfield JC; Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Lamb CA; Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Parkes M; Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Irving PM; Department of Gastroenterology, Guy's and St Thomas' Foundation Trust, London, UK.
Prescott NJ; Department of Medical and Molecular Genetics, King's College London, London, UK.
Hayday AC; Peter Gorer Department of Immunobiology, King's College London at Guy's Hospital Campus, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 Sep 15; Vol. 381 (6663), pp. eadh0301. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Journal Article
MeSH Terms:: Butyrophilins*/genetics
Inflammatory Bowel Diseases*/genetics
Inflammatory Bowel Diseases*/immunology
Receptors, Antigen, T-Cell, gamma-delta*
T-Lymphocyte Subsets*/immunology
Animals ; Humans ; Mice ; Colon/immunology ; Crohn Disease/genetics ; Crohn Disease/immunology ; Intestinal Mucosa/immunology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Autorzy:: Saifuddin A; London North West University Healthcare NHS Trust, London, UK.
Kent AJ; Department of Gastroenterology, King's College Hospital NHS Foundation Trust, London, UK.
Mehta SJ; Department of Gastroenterology, Barts Health NHS Trust, London, UK.
Hicks LC; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Gonzalez HA; Department of Inflammatory Bowel Disease, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of Gastroenterology, University of Hull, Hull, UK.
Segal JP; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Brookes MJ; Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK.
Subramanian S; Department of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.; Department of Gastroenterology, University of Liverpool, Liverpool, UK.
Bhala N; Department of Gastrointestinal Medicine, Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Applied Health Research, Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
Conley TE; Department of Gastroenterology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Patel KV; Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.
Lamb CA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Walker GJ; Department of Gastroenterology, Torbay and South Devon NHS Foundation Trust, Torquay, UK.
Kennedy NA; Department of Inflammatory Bowel Disease, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group, University of Exeter, Exeter, UK.
Sebastian S; Department of Inflammatory Bowel Disease, Hull University Teaching Hospitals NHS Trust, Hull, UK.; Department of Gastroenterology, University of Hull, Hull, UK.; Pokaż więcej
Corporate Authors:: PREPARE-IBD Collaborators
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (10), pp. 1460-1474. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: COVID-19*
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/complications
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/complications
Crohn Disease*/epidemiology
Humans ; Pandemics ; Ustekinumab ; State Medicine ; Cohort Studies ; Adrenal Cortex Hormones/therapeutic use ; Prednisolone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients.
Autorzy:: Hawthorne AB; Department of Gastroenterology, Cardiff & Vale University Health Board, Cardiff, UK.; Cardiff University, Cardiff, UK.
Glatter J; Crohn's & Colitis UK, Hatfield, UK.
Blackwell J; Department of Gastroenterology, St George's University of London, London, UK.
Ainley R; Crohn's & Colitis UK, Hatfield, UK.
Arnott I; Edinburgh IBD Unit, Western General Hospital, Edinburgh, UK.
Barrett KJ; New Road Surgery, Hertfordshire, UK.
Bell G; IBDUK, Hatfield, UK.
Brookes MJ; Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Research Institute in Healthcare Science, University of Wolverhampton, Wolverhampton, UK.
Fletcher M; IBDUK, Hatfield, UK.
Muhammed R; Department of Paediatric Gastroenterology, Birmingham Children's Hospital, Birmingham, UK.
Nevill AM; Faculty of Health Education and Wellbeing, University of Wolverhampton, Wolverhampton, UK.
Segal J; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
Selinger CP; Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; University of Leeds, Leeds, UK.
St Clair Jones A; Department of Pharmacy, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK.
Younge L; Department of Gastroenterology, St Marks Hospital, Harrow, UK.
Lamb CA; Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Pokaż więcej
Corporate Authors:: IBD UK Board IBD UK Task & Finish Group
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Aug; Vol. 56 (4), pp. 625-645. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/therapy
Child, Preschool ; Chronic Disease ; Humans ; Male ; Patient Reported Outcome Measures ; Quality of Health Care ; Surveys and Questionnaires ; United Kingdom ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Editorial: quality assessment in IBD in high resource countries can lead to quality improvement clues for IBD management worldwide-authors' reply.
Autorzy:: Hawthorne AB; Department of Gastroenterology, Cardiff & Vale University Health Board, Cardiff, UK.; Cardiff University, Cardiff, UK.
Lamb CA; Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Aug; Vol. 56 (4), pp. 743.
Typ publikacji:: Editorial; Comment
MeSH Terms:: Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/therapy
Quality Improvement*
Humans

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
Autorzy:: Dart RJ; School of Immunology and Microbial Sciences, King's College London, London, UK.; Department of Gastroenterology, University College London Hospital, UK.
Ellul P; Gastroenterology Division, Mater Dei Hospital, Msida, Malta.
Scharl M; Department of Gastroenterology and Hepatology, University Hospital Zürich, Switzerland.
Lamb CA; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2021 Sep 25; Vol. 15 (9), pp. 1407-1409.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*
Inflammatory Bowel Diseases/*therapy
Congresses as Topic ; Drug Monitoring ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.
Autorzy:: Lamb CA; Newcastle upon Tyne, UK.
Sebastian S; Hull, UK.
Kent AJ; London, UK.
Segal JP; London, UK.
Gonzalez HA; Hull, UK.
Brookes MJ; Wolverhampton, UK.
Mehta SJ; London, UK.
Subramanian S; Liverpool, UK.
Bhala N; Birmingham, UK.
Hicks LC; London, UK.
Conley TE; Liverpool, UK.
Patel KV; London, UK.
Walker GJ; Torquay, UK.
Kennedy NA; Exeter, UK.; Pokaż więcej
Corporate Authors:: PREPARE-IBD Study Group
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1236-1240.
Typ publikacji:: Letter; Comment
MeSH Terms:: COVID-19*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Cohort Studies ; Humans ; SARS-CoV-2 ; United Kingdom/epidemiology

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment.
Autorzy:: Lamb CA; Newcastle University, Newcastle upon Tyne, UK.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Mansfield JC; Newcastle University, Newcastle upon Tyne, UK.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Kirby JA; Newcastle University, Newcastle upon Tyne, UK.
Keir ME; Genentech Inc., South San Francisco, CA, USA.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Jul 25; Vol. 13 (7), pp. 956-957.
Typ publikacji:: Letter; Comment
MeSH Terms:: Antibodies, Monoclonal, Humanized*
Inflammatory Bowel Diseases*
Biomarkers ; Humans

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation.
Autorzy:: Ichikawa R; Genentech Research and Early Development, South San Francisco, California, USA.
Lamb CA; Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Eastham-Anderson J; Genentech Research and Early Development, South San Francisco, California, USA.
Scherl A; Genentech Research and Early Development, South San Francisco, California, USA.
Raffals L; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Faubion WA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Bennett MR; Newcastle University, Newcastle upon Tyne, UK.
Long AK; Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Mansfield JC; Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Kirby JA; Newcastle University, Newcastle upon Tyne, UK.
Keir ME; Genentech Research and Early Development, South San Francisco, California, USA.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2018 Nov 09; Vol. 12 (10), pp. 1191-1199.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Colon*/immunology
Colon*/pathology
Ileum*/immunology
Ileum*/pathology
Inflammatory Bowel Diseases*/immunology
Inflammatory Bowel Diseases*/pathology
Adult ; Antigens, CD ; Biopsy/methods ; Correlation of Data ; Endoscopy, Digestive System/methods ; Female ; Gene Expression Profiling ; Humans ; Immunohistochemistry ; Inflammation/immunology ; Inflammation/pathology ; Integrin alpha Chains ; Intestinal Mucosa/immunology ; Intestinal Mucosa/pathology ; Male ; Middle Aged